Ironwood Pharmaceuticals IRWD Income Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| $106.51M+159% | $47.71M-47.3% | $122.06M+33.3% | $85.24M-9.7% | $41.14M-45.1% | ||
| $21.94M-20.0% | $21.86M-13.9% | $22.47M-24.7% | $23.37M-23.1% | $27.43M+6.3% | ||
| $12.03M-50.4% | $19.29M-42.6% | $21.91M-39.3% | $16.8M-54.6% | $24.26M-35.5% | ||
| $33.93M-51.7% | $40.9M-30.7% | $46.58M-29.4% | $39.92M-42.5% | $70.25M+10.0% | ||
| $72.57M+349% | $6.81M-78.4% | $75.48M+194% | $45.32M+81.5% | -$29.11M-364% | ||
| 68.1%+139pp | 14.3%-20.5pp | 61.8%+33.9pp | 53.2%+26.7pp | -70.7%-85.5pp | ||
| $9.14M+13.3% | $7.89M-11.5% | $8.43M-10.5% | $8.36M+11.9% | $8.07M+11.6% | ||
| -$7.4M-3.3% | -$6.35M+15.3% | -$7.46M+9.7% | -$7.5M-22.9% | -$7.16M-18.2% | ||
| $65.17M+280% | $455K-98.1% | $68.02M+292% | $37.82M+100% | -$36.27M-832% | ||
| $24.4M+2,090% | $2.73M-87.4% | $27.94M+104% | $14.22M-27.9% | $1.11M-87.8% | ||
| $40.77M+209% | -$2.28M-201% | $40.08M+999% | $23.6M+2,844% | -$37.39M-798% | ||
| 38.3%+129pp | -4.8%-7.3pp | 32.8%+28.9pp | 27.7%+28.6pp | -90.9%-85.3pp | ||
| $0.24+204% | -$0.01-200% | $0.23+1,050% | $0.14+1,500% | -$0.23-667% | ||
| $73.02M+355% | $7.27M-77.1% | $75.96M+193% | $45.79M+81.1% | -$28.63M-353% | ||
| 68.6%+138pp | 15.2%-19.9pp | 62.2%+33.9pp | 53.7%+26.9pp | -69.6%-84.7pp | ||
| $72.57M+349% | $6.81M-78.4% | $75.48M+194% | $45.32M+81.5% | -$29.11M-364% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What is Ironwood Pharmaceuticals's revenue?
- Ironwood Pharmaceuticals (IRWD) generated $361.5M in revenue over the trailing twelve months, up 13.8% year over year.
- Is Ironwood Pharmaceuticals profitable?
- Ironwood Pharmaceuticals reported $102.2M in net income over the trailing twelve months, a 28.3% net margin.
- What are Ironwood Pharmaceuticals's profit margins?
- Gross margin is 99.2% and operating margin is 55.4%, with a 28.3% net margin.
- What is Ironwood Pharmaceuticals's earnings per share?
- Ironwood Pharmaceuticals's diluted EPS over the trailing twelve months is $0.60.
- Where does Ironwood Pharmaceuticals's income statement data come from?
- Every line is extracted from Ironwood Pharmaceuticals's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
